This document summarizes guidelines on the use of antenatal corticosteroids. It states that a single course of antenatal corticosteroids between 24-34 weeks of gestation significantly reduces neonatal death, respiratory distress syndrome, and intraventricular hemorrhage, with no known benefits or harms for the mother. It provides guidance on appropriate patients, timing, dosage, and considerations for particular clinical contexts. Repeating courses weekly is not recommended due to potential effects on growth, though a second course may be considered in limited circumstances.